Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women

European Journal of Clinical Nutrition

Volumn 62, Issue 8, 2008, Pages 1010-1021

  Barbosa, P R ^a   Stabler, S P ^b   Machado, A L K ^a   Braga, R C ^a   Hirata, R D C ^a   Hirata, M H ^a   Sampaio Neto, L F ^c   Allen, R H ^b   Guerra Shinohara, E M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF COLORADO   (United States)

^c PONTIFÍCIA UNIVERSIDADE CATÓLICA DE SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; CREATININE; FOLIC ACID; HOMOCYSTEINE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); METHYLMALONIC ACID; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; NUTRIENT CONCENTRATION; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANT WOMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VITAMIN BLOOD LEVEL;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADOLESCENT; ADULT; ALLELES; ANALYSIS OF VARIANCE; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENE FREQUENCY; GENOTYPE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); METHYLMALONIC ACID; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREGNANCY; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; VITAMIN B 12; YOUNG ADULT;

EID: 49349102119     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602810     Document Type: Article

References (52)

1. Adams Jr MJ, Khoury MJ, Scanlon KS, Stevenson RE, Knight GJ, Haddow JE et al. (1995). Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology 51 311-317.
2. Alessio AC, Annichino-Bizzacchi JM, Bydlowski SP, Ebertin MN, Vellasco AP, Hoehr NF (2004). Polymorphisms in the methylene-tetrahydrofolate reductase and methionine synthase reductase genes and homocysteine levels in Brazilian children. Am J Med Genet A 128, 256-260.
3. Al-Gazali LI, Padmanabhan R, Melnyk S, Yi P, Pogribny IP, Pogribna M et al. (2001). Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down Syndrome and Neural Tube Defects. Am J Med Genet 103, 128-132.
4. Allen RH, Stabler SP, Savage DG, Lindenbaum J (1993). Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J 7, 1344-1353.
5. Andersson A, Hultberg B, Brattstrom L, Isaksson A (1992). Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem 30, 377-379.
6. Arruda VR, Siquiera LH, Gonçalves MS, Von Zuben PM, Soares MC, Menezes R et al. (1998). Prevalence of the mutation C677T in the methylenetetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 78, 332-335.
7. Bruinse HW, van den Berg H (1995). Changes of some vitamin levels during and after normal pregnancy. Eur J Obstet Gynecol Reprod Biol 61 31-37.
8. Carmel R (1999). Ethnic and racial factors in cobalamin and its disorders. Semin Hematol 36, 88-100.
9. Chanarin I (1990). The Megaloblastic Anemias, 3rd edn. Blackwell Scientific Publications: London.
10. Chango A, Boisson F, Qilliot D, Droesch S, Pfister M, Fillon-Emery N et al. (2000). The effect of 677CT and 1298AC mutations on plasma homocysteine and 5, 10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 83, 593-596.
11. Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R et al. (1999). Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 84, 151-157.
12. Clarke S, Banfield K (2001). S-Adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobsen DW (eds.). Homocysteine in Health and Disease. Cambridge University Press: Cambridge UK. pp 63-78.
13. Cunha ALA, Hirata M, Kim CA, Guerra-Shinohara EM, Nonoyama K, Hirata RDC (2002). Metabolic effects of C677T and A1298C mutations at the MTHFR gene in Brazilian children with Neural Tube Defects. Clin Chim Acta 318, 139-143.
14. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ et al. (2002). A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA. 99, 5606-5611.
15. Friso S, Girelli D, Trabetti E, Olivieri O, Guarini P, Pignatti PF et al. (2005). The MTHFR 1298A > C polymorphism and genomic DNA methylation in human lymphocytes. Cancer Epidemiol Biomarkers Prev 14, 938-943.
16. Frosst P, Blom HJ, Milos R, Gyette P, Sheppard CA, Matthews RG et al. (1995). A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase (MTHFR). Nat Genet 10, 111-113.
17. Gaughan DJ, Kluijtmans LAJ, Barbaux S, McMaster D, Young IS, Yarnell JWG et al. (2001). The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157, 451-456.
18. Guerra-Shinohara EM, Morita OE, Pagliusi RA, Blaia-d'Avila VL, Allen RH, Stabler SP (2007). Elevated serum S-adenosylhomocysteine in cobalamin-deficient megaloblastic anemia. Metabolism 56, 339-347.
19. Guerra-Shinohara EM, Morita OE, Peres S, Pagliusi BA, Sampaio Neto LF, D'Almeida V et al. (2004). Low S-adenosylmethionine/ S-adenosylhomocysteine ratio associated with vitamin deficiency in Brazilian pregnant women and newborns. Am J Clin Nutr 80, 1312-1321.
20. Guerra-Shinohara EM, Paiva AA, Rondó PHC, Yamasaki K, Terzi CA, D'Almeida V (2002). Relationship between total homocysteine and folate levels in pregnant women and their newborn babies according to maternal serum levels of vitamin B12. BJOG 109, 784-791.
21. Hanson NQ, Aras O, Yang F, Tsai MY (2001). C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: Incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 47, 661-666.
22. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JW, Young IS et al. (1999). Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 17, 298-309.
23. Holmes VA, Wallace JMW, Alexander HD, Gilmore WS, Bradbury I, Ward M et al. (2005). Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation. Clin Chem 51, 629-634.
24. Jacques PF, Bostom AG, Selhub J, Rich S, Ellison RC, Eckfeldt JH et al. (2003). Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis 166, 49-55.
25. Kirke PN, Molloy AM, Daly LE, Burker H, Weir DG, Scott JM (1993). Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86, 703-708.
26. Klerk M, Lievers KJA, Kluijtmans LAJ, Blom HJ, den Heijer M, Schorten EG et al. (2003). The 2756A > G variant in the gene encoding methionine synthase: Its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study. Thromb Res 110, 87-91.
27. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D et al. (1998). Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 95, 3059-3064.
28. Miriuka SG, Langman LJ, Evrovski J, Miner SE, D'Mello N, Delgado DH et al. (2005). Genetic polymorphisms predisposing to hyper-homocysteinemia in cardiac transplant patients. Transpl Int 18, 29-35.
29. Molloy AM, Mills JL, McPartlin J, Kirke PN, Scott JM, Daly S (2002). Maternal and fetal plasma homocysteine concentrations at birth: The influence of folate, vitamin B12, and the 5, 10-methylenetetrahydrofolate reductase 677C→T variant. Am J Obstet Gynecol 186, 499-503.
30. Mtiraoui N, Zammiti W, Ghazouani L, Braham NJ, Saidi S, Finan RR et al. (2006). Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses. Reproduction 131, 395-401.
31. Murphy MM, Scott JM, Arija V, Molloy AM, Fernandez-Ballart JD (2004). Maternal homocysteine before conception and throughout pregnancy predicts fetal homocysteine and birth weight. Clin Chem 50, 1406-1412.
32. Murphy MM, Scott JM, Mcarlim JM, Fernandez-Ballart JD (2002). The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr 76, 614-619.
33. Nelen WLDM, Blom HJ, Steegers EAP, Heijer MD, Thomas CMG, Eskes TAAB (2000). Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol 95, 519-524.
34. Olteanu H, Munson T, Banerjee R (2002). Differences in the efficiency of reductive activation of methionine synthase and exogeneous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 45, 13378-13385.
35. Pereira AC, Schettert IS, Morandini Filho AAF, Guerra-Shinohara EM, Krieger JE (2004). Methylenetetrahydrofolate reductase (MTHFR) c677t gene variant modulates the homocysteine folate correlation in a mild folate-deficient population. Clin Chim Acta 340, 99-105.
36. Russo GT, Friso S, Jacques PF, Rogers G, Cucinotta D, Wilson PW et al. (2003). Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framigham Offspring Study Cohort. J Nutr 133, 3416-3421.
37. Salazar LA, Hirata MH, Cavalli SA, Machado MO, Hirata RDC (1998). Optimized procedure for DNA isolation from fresh and cryo-preserved clotted human blood useful in clinical molecular testing. Clin Chem 44, 1748-1750.
38. Scott JM, Dinn JJ, Wilson P, Weir DG (1981). Pathogenesis of subacute combined degeneration: A result of methyl group deficiency. Lancet 2, 334-337.
39. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H et al. (1999). The 'thermolabile' variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64, 1045-1055.
40. Stabler SP, Allen RH (2004). Quantification of serum and urinary S-adenosylmethionine and S-adenosylhomocysteine by stable-isotope-dilution liquid chromatography-mass spectrometry. Clin Chem 50, 365-372.
41. Stabler SP, Allen RH, Fried LP, Pahor M, Kittner SJ, Penninx BWJH et al. (1999). Racial differences in prevalence of cobalamin and folate deficiencies in disable elderly women. Am J Clin Nutr 70, 911-919.
42. Stabler SP, Marcell PD, Podell ER, Allen RH (1987). Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 162, 185-196.
43. Stabler SP, Marcell PD, Podell ER, Allen RH, Lindenbaum J (1986). Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry. J Clin Invest 77, 1606-1612.
44. Steen MT, Boddie AM, Fisher AJ, MacMahon W, Saxe D, Sullivan KM et al. (1998). Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid. Prenat Diagn 18, 545-555.
45. Unfried G, Griesmacher A, Weismüller W, Nagele F, Huber JC, Tempfer CB (2002). The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage. Obstet Gynecol 99, 614-619.
46. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK et al. (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural tube defects? Am J Hum Genet 62, 1044-1051.
47. Vaughn JD, Bailey LB, Shelnutt KP, Von-Castel Dunwoody KM, Maneval DR, Davis SR et al. (2004). Methionine synthase reductase 66A → G polymorphism is associated with increased plasma homocysteine concentration when combined with homozygous methylenetetrahydrofolate reductase 677C → T variant. J Nutr 134, 1958-2990.
48. Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR (1999). Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 180, 660-664.
49. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H et al. (1999). A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 67, 317-323.
50. Yamada K, Gravel RA, Toraya T, Matthews RG (2006). Human methionine synthase reductase is a molecular chaperone for human methionine synthase. Proc Natl Acad Sci USA 103, 9476-9481.
51. Zetterberg H (2004). Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol 2 7.
52. Zetterberg H, Regland B, Palmér M, Ricksten A, Palmqvist L, Rymo L et al. (2002). Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted. Eur J Hum Genet 10, 113-118.